ElleVet Sciences Promotes Haley Israelson to Chief Executive Officer Posted On Published October 31, 2024 Updated October 31, 2024
The Street Dog Coalition Receives RV From ElleVet Sciences in Support of One Health Mission Posted On Published March 18, 2024 Updated June 10, 2024
New Clinical Studies Demonstrate Efficacy of ElleVet Sciences’ CBD + CBDA  for Expanded List of Pet Health Conditions Posted On Published January 10, 2024 Updated January 16, 2024
Breakthrough Study Shows Safety of CBD+CBDA Regarding Drug Interactions in Dogs Posted On Published September 12, 2023 Updated October 10, 2023
ElleVet Sciences Issued a Patent for Proprietary CBD+CBDA Formulation Posted On Published August 29, 2023 Updated January 16, 2024
ElleVet Sciences, the Leading Pet CBD+CBDA Brand in the United States, Expands into Europe Posted On Published February 15, 2023 Updated February 15, 2023
ElleVet Sciences Announces the Publication of the Results of Seizure Study Using their Proprietary CBD+CBDA Oil on Dogs Posted On Published August 23, 2022 Updated August 13, 2024
ElleVet Sciences receives 2022 NASC Visibility and Lancelot Awards Posted On Published July 1, 2022 Updated July 1, 2022
It’s not the CB1 and CB2 receptors after all Posted On Published June 10, 2022 Updated June 13, 2022
ElleVet Sciences announces the publication of the results of their atopic dermatitis study using their proprietary CBD+CBDA oil on dogs Posted On Published June 2, 2022 Updated June 7, 2022
ElleVet Sciences shares results of CBD + CBDA pruritus study at NAVDF 2022 Posted On Published April 21, 2022 Updated June 21, 2023
The Only CBD+CBDA Product Proven Safe for Cats Posted On Published January 7, 2022 Updated August 13, 2024
